Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Company

MacroGenics

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 1 TRIAL

A Study of MGC026 in Participants With Advanced Solid Tumors

ClinicalTrials.gov

Phase 1 dose-escalation study of a novel biologic in early-stage development; no results are posted in this registry record, only planned study design and safety endpoints.

PreliminaryAdvanced Cancer NCT06242470 MacroGenics

Reported

Planned sample size250

PhasePhase 1

Primary outcome measureNumber of participants with adverse events,…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support